Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4843644

Fc1cccc(-c2nc3cc(Br)cnc3[nH]2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.49
SLC9A1 P19634 1/20 0.41
HDAC6 Q9UBN7 2/20 0.39
DHODH Q02127 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HPGDS O60760 1/20 0.39
PDE2A O00408 1/20 0.39
ULK1 O75385 1/20 0.38
GRK6 P43250 1/20 0.38
KMO O15229 2/20 0.38
ATR Q13535 1/20 0.38
EGLN1 Q9GZT9 1/20 0.37
KIT P10721 1/20 0.37
MAPT P10636 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13607845 0.89 MGAM (0.44) PIN1HDAC6HDAC3HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL5262965 0.85 PIN1 (0.51) PIN1SLC9A1HDAC6
Trifluoroacetic Acid SCHEMBL4841475 0.80 DYRK1B (0.38) HDAC6DHODH
Trifluoroacetic Acid SCHEMBL4845932 0.79 DGAT1 (0.45) HDAC6EGLN1KIT
Trifluoroacetic Acid SCHEMBL4842876 0.79 CHEK2 (0.45)
Trifluoroacetic Acid SCHEMBL4842729 0.79 AURKA (0.52) PDE2AMAPT
Trifluoroacetic Acid SCHEMBL4834909 0.79 HDAC6 (0.47) HDAC6DHODHHDAC3HDAC1HDAC2
SCHEMBL13607863 0.79 CYP1A2 (0.53) PIN1KIT
Trifluoroacetic Acid SCHEMBL4844656 0.79 PTGES (0.47) HDAC6HDAC3MGAM
Trifluoroacetic Acid SCHEMBL5260040 0.78 ALDH1A1 (0.48) HDAC6DHODHHDAC1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 PIN1 3350/4885SLC9A1 3790/4885HDAC6 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.